Profil
Thomas P.
Lynch worked as Secretary, Chief Legal & Compliance Officer at Nuwellis, Inc. from 2018 to 2021.
Prior to that, he was Senior Legal Counsel at Novartis Corp.
from 2012 to 2015 and Secretary, Chief Administrative Officer & EVP at Orexigen Therapeutics, Inc. from 2017 to 2018.
Lynch also served as Head-Legal & Compliance at Novartis Pharma AG.
Lynch received his undergraduate degree from Stanford University, his graduate degree from the University of St. Thomas, and his graduate degree from Boston College Law School.
Anciens postes connus de Thomas P. Lynch
| Sociétés | Poste | Fin |
|---|---|---|
| NUWELLIS, INC. | Compliance Officer | 07/06/2021 |
| OREXIGEN THERAPEUTICS, INC. | President | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | General Counsel | 01/11/2015 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Compliance Officer | - |
Formation de Thomas P. Lynch
| Stanford University | Undergraduate Degree |
| University of St. Thomas | Graduate Degree |
| Boston College Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NUWELLIS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
